Approved for Prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age. Contains four recombinant Neisseria meningitidis serogroup B proteins (NadA, fHbp, NHBA, and PorA). These surface-exposed antigens stimulate bactericidal antibodies that kill meningococcal serogroup… Side effects, costs, interactions, manufacturer, and…
Loading full data from Know Your Drugs Institute…